3rd Annual Peptides Congress 2016

Over 400 peptides, proteins and biosimilars attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key advancements in peptides research and therapeutics

Two-day interactive conference addressing the following topic areas:

  • Advances In Peptides Research And Technologies
  • Case Studies In Peptide Therapeutics

Co-located with the 9th Annual Proteins & Antibodies Congress and 4th Annual Biosimilars & Biobetters Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to announce the 3rd Annual Peptides Congress, taking place on 18 – 19 April 2016, at the Novotel London West, London, UK. The event provides a unique opportunity for over 400 senior-level biologics experts to network, exchange experiences and engage in scientific discussions about the current results and future challenges of peptides research and therapeutics.

The peptides market represents a rapidly expanding area of pharmaceutical research. The improved peptide synthesis technologies, recent developments in macrocyclic and cell-penetrating peptides and the unquestionable vast potential of peptides in therapeutics all underpin the promising future that has been forecasted for the industry. Experts have also highlighted that the global peptide therapeutics market will reach $23.7 billion by 2020.  

On day one our highly esteemed speakers will focus on the recent advancements in peptides research and technologies. Presentations will cover important areas such as novel formulation strategies for peptides, improved half-life extension methods and updates in macrocyclic, cell-penetrating and cyclic peptides. Technological advancements in peptide synthesis, screening and modification will also be addressed.

On day two of the conference delegates will have the exclusive opportunity to hear presentations covering peptide therapeutics. Our highly distinguished experts will discuss the recent improvements in peptide drug delivery systems, utilising peptides in the clinic and peptide drug conjugates. Presentations will also extend to the exciting outcomes of antimicrobial peptides research as well as peptide drug conjugates.

The 3rd Annual Peptides Congress forms part of Oxford Global’s highly successful Biologics Series. For more information on other events in this series, please see the details below:

 


Proteins & Antibodies, Peptides and Biosimilars & Biobetters 2016 Sponsors:

Proteins & Antibodies, Peptides and Biosimilars & Biobetters 2015 Sponsors:

IBIS.jpgMRC.jpgAffibody.jpgNovozymes.jpgSanger.jpgAgilent copy.jpgMetanomics.jpgPfizer 2.jpgGlenbervie.jpgSGS.jpgChelatec.jpgShire.jpgAIMM.jpg

Media Partners